Cutting-edge science for animal health
We developed an advanced drug discovery platform for cats
Kedi’s discovery platform combines experimental and computational biology to enable a new era in veterinary therapies.
Our technology facilitates the discovery and development of antibody and peptide therapies that match the feline immune system. Kedi’s approach is fast, cost-effective and scalable to other species without any animal experiments.
The core of Kedi’s platform is highly diverse, fully feline phage display libraries. These allow the discovery of species-specific antibody therapies for cats, replacing the traditional path of rodent immunization with a more humane alternative.
Our internal drug discovery campaigns showed industry-leading hit rates, yielding a high number of potent antibody candidates. We established an experimental setup to deeply characterize and validate their function.
Unique genetic insights into animals empower new therapies
We use molecular biology tools to analyze ethically obtained samples from healthy and diseased cats. The results help build a proprietary database of feline health, used to optimize our drug candidates.
Guided by data and a love for cats, Kedi is developing half-life extended therapeutics that require less frequent administrations.
AI for veterinary drug development
We combine our unique data with public resources and fine-tune antibody AI models to target species. Our computational drug development framework decreases the risk and intensity of lab work. Kedi builds and operates multiple in silico workflows to optimize drug candidates for low immunogenicity and high manufacturability.
Our state-of-the-art technology doesn’t require any animal experiments
Kedi conducts no pre-clinical experiments in animals. Instead, we combine the existing knowledge from human drug research with ethically obtained, proprietary animal data.
Each of our R&D programs is based on a careful consideration of numerous similarities and discrepancies in the animal kingdom. We evaluate protein structures, disease pathways, genomics, and clinical findings to accelerate drug development — cautiously.
Kedi generates unique scientific insights into animal biology with the hope of reducing overall animal experimentation.
A collaborative approach to deliver new medicines fast
Most of our experimental work takes place in the external laboratories of trusted contract research organizations based in Europe. This helps us stay lean and build on existing, specialized labs with experienced workforce.
We are always looking to partner with innovative companies who push the boundaries of healthcare and technology for both humans and animals.